Metabolomycs

Metabolomycs, Inc. is a biotechnology company headquartered in Long Beach, California, and a pioneer in applying next-generation metabolomics to clinical research on human diseases. Metabolomycs' platform utilizes mass spectrometry technology to identify inborn errors of metabolism that contribute to many human diseases by leveraging biochemical signatures, offering opportunities for early diagnosis and improved treatment. Metabolomycs’ analysis unveils the secrets of metabolism.